Laboratory & Diagnostics

BioEdge Expands Batch-Level COA Access for Research Peptides

Miami – September 16, 2026 -- BioEdge Research Labs has begun publishing batch-specific Certificates of Analysis (COAs) directly on its product pages, allowing laboratory customers to verify identity and purity data for the exact lot they receive rather than relying on aggregated supplier summaries.

Each lot now carries its own matched documentation

Instead of a single certificate applied across multiple production runs, every vial supplied by the Miami-based company is assigned a lot number tied to a corresponding COA, letting researchers cross-check the physical material against its specific record.

Independent labs handle identity and purity testing

The underlying analysis is conducted by a third-party laboratory rather than BioEdge itself, covering identity verification via mass spectrometry, purity assessment via high-performance liquid chromatography, and contaminant screening.

Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Image
Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Statesville, N.C. – – September 16, 2026 -- Kewaunee Scientific Corporation (NASDAQ: KEQU) reported first-quarter fiscal 2027 sales of $66.3 million, down 6.7% from $71.1 million a year earlier, even as order backlog rose to $169.0 million from $165.9 million at the end of April.

Net earnings drop to $1.7 million on lower manufacturing volumes

Pre-tax earnings fell 34.7% to $2.56 million from $3.92 million in the prior-year quarter, while net earnings declined to $1.706 million from $3.093 million. Diluted earnings per share came in at $0.58, down from $1.04. EBITDA for the quarter totaled $4.525 million versus $6.32 million a year ago. Backlog, while up sequentially, remains well below the $205.0 million recorded on September 16, 2026.

Dermatologist Zirvi Honored by Marquis Who's Who as Illumina IP Case Concludes

Image
Dermatologist Zirvi Honored by Marquis Who's Who as Illumina IP Case Concludes

Uniondale, N.Y. – September 16, 2026 -- Marquis Who's Who has included Monib A. Zirvi, MD, PhD, in its biographical volumes, recognizing more than two decades of work in dermatology and diagnostic genetics as a related patent dispute involving Illumina Inc. reaches final resolution.

Zirvi Has Practiced Dermatology at Summit Health Since 2004

Dr. Zirvi has served as a dermatologist with Summit Health and as an attending physician at Atlantic Health System's Overlook Medical Center since 2004, focusing on general dermatology, skin cancer detection and hair and nail disorders. Summit Health named him among its 2026 Castle Connolly Top Doctors. He is board certified by the American Board of Dermatology and holds a courtesy instructor appointment in microbiology and immunology at Weill Cornell Medicine, where he earned his MD and PhD.

PQM Endorses NKF Measure to Expand Annual CKD Testing

New York – September 15, 2026 -- The Partnership for Quality Measurement (PQM) has endorsed a National Kidney Foundation (NKF) quality measure that tracks annual kidney testing for adults with diabetes and/or high blood pressure, a move aimed at closing a diagnostic gap affecting an estimated 37 million U.S. adults with chronic kidney disease (CKD).

Measure tracks two annual tests for at-risk adults aged 18 to 85

The endorsed measure, Rate of Annual Kidney Health Evaluation Among Adults with Diabetes and/or Hypertension, monitors whether patients receive both an estimated glomerular filtration rate (eGFR) blood test and a urine albumin-creatinine ratio (uACR) test within a measurement year. The combination helps clinicians identify CKD and assess risk of disease progression and cardiovascular complications.

Laboratory Mixers Market to Hit $2.74B by 2031, Says MarketsandMarkets

Image
Laboratory Mixers Market to Hit $2.74B by 2031, Says MarketsandMarkets

Delray Beach, Fla. – September 12, 2026 -- The global laboratory mixers market is projected to reach USD 2.74 billion by 2031, up from USD 2.27 billion in 2026, growing at a compound annual rate of 3.5%, according to a new report from MarketsandMarkets.

Asia Pacific to outpace global growth with 6.5% CAGR

The Asia Pacific region is forecast to grow at a 6.5% CAGR through 2031, outpacing the global average, driven by expanding research laboratory capacity and biopharmaceutical development. North America is expected to retain the largest overall market share in 2031, supported by a dense concentration of research universities, biomedical institutes, contract research organizations, and clinical laboratories that maintain a large installed base of vortex mixers, magnetic stirrers, shakers, and thermal mixers.

Anitoa Adds Cloud Connectivity, Hardware Security to Portable qPCR Devices

Image
Anitoa Adds Cloud Connectivity, Hardware Security to Portable qPCR Devices

Sunnyvale, Calif. – September 11, 2026 -- Anitoa Systems, LLC. has integrated cloud connectivity and enterprise-grade security into its portable qPCR molecular testing instruments, enabling remote operation and centralized data aggregation for disease surveillance.

Remote access replaces physical tethering to diagnostic hardware

Users can now control Anitoa's qPCR devices via a secure HTTPS interface through a cross-platform web application, allowing remote data collection, experiment setup, and real-time monitoring from any location. The shift removes the requirement that operators remain physically present with field-deployed instruments.

Lab Glassware Market to Hit $9.17B by 2031 as Plasticware Surges

Image
Lab Glassware Market to Hit $9.17B by 2031 as Plasticware Surges

Delray Beach, Fla. – – September 11, 2026 -- The global laboratory glassware market is projected to grow from USD 7,630 million in 2026 to USD 9,170 million by 2031, a compound annual growth rate of 4.0%, according to new data from MarketsandMarkets.

Plasticware commands 68% of market share as labs shift away from traditional glass

Plasticware, which includes pipettes, beakers, racks, bottles and containers, accounted for 68% of the laboratory glassware market in 2025. Within this segment, polyethylene products are forecast to post the fastest growth rate in the category, at 4.5% CAGR between 2026 and 2031. The shift reflects laboratory demand for lightweight, shatter-resistant, single-use consumables that improve contamination control and reduce costs across pharmaceutical, biotechnology, contract research organization and food & beverage labs.

Legionella Found in 17% of NYC Water Samples Outside Cooling Towers

Image
Legionella Found in 17% of NYC Water Samples Outside Cooling Towers

Washington – September 09, 2026 -- Independent testing commissioned by the Alliance to Prevent Legionnaires' Disease (APLD) found Legionella bacteria in 17 percent of 109 water samples collected from sinks, showers, hose bibs and other fixtures across the Upper East Side outbreak zone, results the group says expose gaps in New York City's current prevention strategy.

Testing detected live, culturable Legionella pneumophila serogroup 1 across all three sampled zip codes

The independent consultant collected samples in mid-July across zip codes 10128, 10028 and 10075, the area the City identified as the outbreak zone. Legionella was found in 19 buildings, including 10 exterior hose bibs, seven sinks, one shower and a decorative fountain. Positive samples showed Legionella concentrations ranging from less than 1 to 390 CFU/mL, with Legionella pneumophila serogroup 1 confirmed in all three zip codes.

Thermo Fisher Scientific Expands Biotech and Diagnostic Portfolio With New Instruments and CDMO Services

Image

SHERIDAN, WYOMING - April 13, 2026 - Thermo Fisher Scientific continues to broaden its life science and laboratory portfolio across bioprocessing, molecular diagnostics, and gene therapy, positioning itself as an integrated supplier for biotechnology and biopharma customers from discovery through commercial manufacturing. The company's German operations offer the full product and service stack - from TaqMan Real-Time PCR assays and Orbitrap Astral mass spectrometers to CDMO and CRO services under the Patheon and PPD brands. New instrument releases targeting water and nutrient analysis, IVD-compliant thermal cycling, and high-resolution mass spectrometry signal continued capital investment in laboratory hardware. The breadth of this portfolio expansion has direct implications for procurement, R&D, and quality teams operating in regulated life science environments.

Philips Launches Cloud-Enabled IntelliSite Pathology Solution on HealthSuite Powered by AWS

Image

SHERIDAN, WYOMING - April 01, 2026 - Pathology laboratories operating hybrid analog-digital environments face mounting pressure to eliminate on-premise infrastructure bottlenecks as image volumes grow and AI-enabled diagnostics move closer to routine clinical use. Philips' expansion of its digital pathology portfolio with the cloud-enabled Philips IntelliSite Pathology Solution (PIPS) on HealthSuite, powered by Amazon Web Services (AWS), directly addresses this operational gap by removing the requirement for local server infrastructure while enabling secure, remote access to high-resolution whole-slide images across distributed care sites.